Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

When did reclast come out?

See the DrugPatentWatch profile for reclast

Reclast (zoledronic acid) was approved by the U.S. FDA in February 2002 for osteoporosis in postmenopausal women (and it launched in 2002). If you meant its cancer-related use, that’s a separate, earlier indication under the related product Zometa.



Other Questions About Reclast :

reclast ingredients What is the risk of jaw necrosis with Reclast? Cost of reclast infusion 2026? Generic reclast? Reclast injection cost? Reclast infusion price? Pros and cons of reclast infusion?